Reinhard Brückner

Title: Reinhard Brückner - Innovator in Pharmaceutical Science

Introduction

Reinhard Brückner is a distinguished inventor based in Hannover, Germany. He is recognized for his contribution to the field of pharmaceutical science, particularly in developing novel compounds with therapeutic potential.

Latest Patents

Brückner holds a patent for "Hydronopol derivatives as agonists on human ORL1 receptors." This innovative invention focuses on a group of hydronopol derivatives that act as agonists on human ORL1 (nociceptin) receptors. The patent also covers the preparation of these compounds, pharmaceutical compositions that include a pharmacologically active amount of these derivatives, and their application in treating disorders associated with ORL1 receptors. The compounds are defined by a general formula where specific symbols have defined meanings outlined in the patent description.

Career Highlights

Reinhard Brückner currently works for Solvay Pharmaceuticals, GmbH, where he continues to push the boundaries of pharmaceutical research and development. His focus on innovative treatments demonstrates his commitment to enhancing medical therapies and improving patient outcomes.

Collaborations

Throughout his career, Brückner has collaborated with notable colleagues, including Matthias Mentzel and Dania B Reiche. These partnerships have likely contributed to the advancement of research and the success of their shared projects in the pharmaceutical sector.

Conclusion

Reinhard Brückner's work exemplifies the spirit of innovation in the pharmaceutical industry. His pioneering patent on hydronopol derivatives showcases his dedication to addressing medical challenges through scientific research and development. As he continues his career at Solvay Pharmaceuticals, his contributions are anticipated to lead to further advancements in medication and treatment options for patients.